United States Of America, ex rel et al v Abbott Laboratories, Inc., et al
Case Number:
1:10-cv-00006
Court:
Nature of Suit:
Judge:
-
October 17, 2016
Omnicare Pays $28M In Depakote Kickbacks Case
Nursing home pharmacy Omnicare Inc. will pay $28 million to resolve False Claims Act allegations that it took kickbacks from Abbott Laboratories in exchange for prescribing epilepsy drug Depakote to vulnerable patients, the U.S. Department of Justice announced Monday.
-
October 07, 2015
PharMerica Inks $9M FCA Deal Over Kickback Allegations
The U.S. Department of Justice said on Wednesday that PharMerica Corp. will pay $9.25 million to settle False Claims Act whistleblower charges that it sought and received kickbacks from Abbott Laboratories in exchange for pushing a seizure medication on nursing home patients.
-
July 07, 2015
Omnicare, DOJ Strike Deal In Abbott Labs Kickback Suits
Omnicare Inc. on Tuesday said it was cutting a deal with the U.S. Department of Justice in two Virginia federal suits accusing it of taking kickbacks from Abbott Laboratories Inc. to promote the use of seizure drug Depakote to control its nursing home patients.
-
May 01, 2015
Omnicare Wants To Boot One Relator From FCA Kickback Suit
Omnicare Inc. asked a Virginia federal judge to dismiss entirely one whistleblower's False Claims Act suit against the company, saying Friday he was the second to file with the same facts and doesn't make specific allegations.
-
December 22, 2014
DOJ Intervenes In FCA Suits Accusing Omnicare Of Kickbacks
The U.S. Department of Justice has intervened in two Virginia whistleblower suits accusing Omnicare Inc. of getting tens of millions of dollars worth of kickbacks from Abbott Laboratories Inc. to promote the use of seizure drug Depakote in nursing homes serviced by Omnicare, prosecutors announced on Monday.